口腔癌中的计量化学疗法:一篇评论
Sathya Sethuraman1, Karthikeyan Ramalingam2
1General Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus
|January 3, 2024
概括
计量化学疗法为口腔癌管理提供了一种有希望的,对患者友好的方法. 这种口服治疗,用更低的剂量和更少的副作用,可以改善治疗这种具有挑战性的疾病的遵守性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 口腔癌是一个重大的健康问题,复发率高,预后不佳,往往需要密集的多学科治疗.
- 口腔癌的常规化疗涉及静脉注射基于的药物,这可能会产生大量的副作用和合规问题.
研究的目的:
- 审查有关口腔计量化学疗法在治疗口腔癌的潜在应用现有文献.
- 突出计量学治疗的好处,包括改善患者的服药性,易于施用,以及与传统治疗相比降低毒性.
主要方法:
- 进行了全面的文献搜索,以确定有关口腔计量化学疗法的相关研究.
- 审查的重点是研究检查口腔癌中计量方案的疗效,安全性和患者遵守情况的研究.
主要成果:
- 口服计量化学疗法显示出作为口腔癌有效治疗方式的潜力.
- 这种方法提供了诸如简化管理,较低剂量和更有利的副作用概况等优势,可能会提高患者的坚持.
结论:
- 计量化学疗法在口腔癌的多学科管理中提供了一个可行的以患者为中心的替代方案或辅助方案.
- 进一步的研究是有必要的,以充分确定作用,并优化在口腔癌治疗方案中使用计量学疗法.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
206
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
206
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
295
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
295
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
165
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
165


